Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atovaquone vs Pentamidine for PCP Prophylaxis in HIV Patients Intolerant to TMP/SMX
NCT00002340Phase 3Completed
- Sponsor
- GSK
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atovaquone in Pneumocystis jirovecii pneumonia (PJP), sponsored by GSK. Status: completed.
02
Drugs
atovaquone
03
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT00002340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002340.